Access to the FreeStyle Libre 3 Plus will soon be expanded to all Australians living with type 1 diabetes, with the continuous glucose monitoring sensor available as a standalone device through the NDSS from 1 October, 2026.
The FreeStyle Libre 3 Plus sensor is described as the world’s smallest CGM sensor and is about the same size as a two-dollar coin.
For people managing type 1 diabetes, continuous glucose monitoring can provide a clearer picture of glucose levels throughout the day and night. Instead of relying on finger-prick checks at single points in time, CGM technology tracks glucose trends and sends readings to your device, helping you and your healthcare team make more informed decisions.
Libre 3 Plus has a compact, discreet design, minute-by-minute glucose readings, improved Bluetooth connectivity and a 15-day wear time.
The sensor requires no calibration and meets anzCGM standards for quality, accuracy and performance.
What the launch means
From 1 October, Libre 3 Plus will be available as a standalone sensor, meaning it can be used without an automated insulin delivery (AID) system. This will give eligible Australians with type 1 diabetes another subsidised CGM option, while those who prefer or need to use a reader will still be able to access Libre 2 Plus through the NDSS.
Using Libre 3 Plus as a standalone sensor requires the new Libre app (coming soon to Australia), as it is not compatible with the currently available FreeStyle LibreLink app.
Libre 3 Plus is currently available via the NDSS for use with the Mylife (previously known as YpsoPump) Loop automated insulin delivery system, and integration with the Omnipod 5 system is expected to be announced soon.
Smaller sensor, longer wear
One of the most noticeable changes is the sensor’s size. Libre 3 Plus is designed to be compact and discreet, which may make it easier to wear during work, school, sport and everyday activities.
Its all-in-one applicator is also designed to simplify the process of applying a new sensor.
The 15-day wear time means users will need to change sensors less often than other CGM products. The device takes a glucose reading every minute, providing detailed information that can help identify patterns, respond quickly to highs and lows, and let you review diabetes management with your credentialled diabetes educator or other health professional.
Read more from our credentialled diabetes educator Cate Mitchell about how to make the most of your CGM.
Do you have any questions? Give us a call
Here at the Diabetes WA clinic, we can help you to learn more about the Libre 3 Plus and submit the relevant NDSS form on your behalf when it becomes available on October 1, 2026 – call us to book an appointment.
If you have any questions about the Libre 3 Plus, including your eligibility, NDSS subsidies and getting started, call the free Diabetes WA Helpline on 1300 001 880.
Please note that these sensors will only be available through the NDSS subsidy from October 1, 2026 and cannot be purchased directly from Abbott.
For individuals who do not have a compatible smartphone, who are actively scanning their NovoPen 6 with the currently available LibreLink app, or who prefer to use a reader, Libre 2 Plus remains available via the NDSS subsidy. You can check your device compatibility at mobilecheck.com.au or call us.
